Advertisement
Advertisement

EVH

EVH logo

Evolent Health, Inc Class A Common Stock

4.22
USD
Sponsored
-0.42
-9.05%
Jul 24, 15:59 UTC -4
Closed
exchange

After-Market

4.28

+0.06
+1.30%

EVH Earnings Reports

Positive Surprise Ratio

EVH beat 32 of 42 last estimates.

76%

Next Report

Date of Next Report
Aug 06, 2026
Estimate for Q2 26 (Revenue/ EPS)
$603.79M
/
-$0.02
Implied change from Q1 26 (Revenue/ EPS)
+21.67%
/
--
Implied change from Q2 25 (Revenue/ EPS)
+35.89%
/
-80.00%

Evolent Health, Inc Class A Common Stock earnings per share and revenue

On May 07, 2026, EVH reported earnings of -0.02 USD per share (EPS) for Q1 26, beating the estimate of -0.05 USD, resulting in a 61.39% surprise. Revenue reached 496.25 million, compared to an expected 540.02 million, with a -8.11% difference. The market reacted with a +11.49% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 13 analysts forecast an EPS of -0.02 USD, with revenue projected to reach 603.79 million USD, implying an increase of 0.00% EPS, and increase of 21.67% in Revenue from the last quarter.
FAQ
For Q1 2026, Evolent Health, Inc Class A Common Stock reported EPS of -$0.02, beating estimates by 61.39%, and revenue of $496.25M, -8.11% below expectations.
The stock price moved up 11.49%, changed from $3.83 before the earnings release to $4.27 the day after.
The next earning report is scheduled for Aug 06, 2026.
Based on 13 analysts, Evolent Health, Inc Class A Common Stock is expected to report EPS of -$0.02 and revenue of $603.79M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement